Showing results (61-70 of 665) with videos related to
Sort By:
Pageof 67
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 23, 2014
Cancer genomics and inherited riskZsofia K Stadler, Kasmintan A Schrader, Joseph Vijai, et al.Familial Cancer|November 2, 2004
Hereditary ovarian cancer in Ashkenazi JewsLuis Robles-Díaz, Deborah J Goldfrank, Noah D Kauff, et al.American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|January 11, 2012
Beyond the patient: the broader impact of genetic discrimination among individuals at risk of Huntington diseaseYvonne Bombard, JoAnne Palin, Jan M Friedman, et al.European Journal of Human Genetics : EJHG|October 25, 2007
Engagement with genetic discrimination: concerns and experiences in the context of Huntington diseaseYvonne Bombard, Elizabeth Penziner, Oksana Suchowersky, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 17, 2024
Genetics providers' perspectives on the use of digital tools in clinical practiceWhiwon Lee, Daena Hirjikaka, Sonya Grewal, et al.The Lancet. Oncology|April 4, 2018
Medication overuse in oncology: current trends and future implications for patients and societyStephen M Schleicher, Peter B Bach, Konstantina Matsoukas, et al.Medical Care|August 21, 2002
Identifying and measuring hospital characteristics using the SEER-Medicare data and other claims-based sourcesDeborah Schrag, Peter B Bach, Celia Dahlman, et al.Gynecologic Oncology|April 26, 2003
Quality of life in women at risk for ovarian cancer who have undergone risk-reducing oophorectomyMark Robson, Martee Hensley, Richard Barakat, et al.CA: a Cancer Journal for Clinicians|August 23, 2011
Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineJeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, et al.Frontiers in Bioscience (Elite Edition)|January 7, 2014
Clinical features and management of BRCA1 and BRCA2-associated prostate cancerShaheen R Alanee, Emily A Glogowski, Kasmintan A Schrader, et al.Pageof 67